drugset / Trial / NCT03954639

Phase 3, Randomized, Double Blinded, Active Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of EXPAREL Admixed With Bupi vs. Bupi Only Administered as Combined Sciatic and Adductor Canal Nerve Block for Postsurgical Analgesia in Lower Extremity Surgeries

NCT03954639

Phase 3 Withdrawn Pacira Pharmaceuticals, Inc
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a Phase 3, multicenter, randomized, double blinded, active controlled study in approximately 81 subjects undergoing lower extremity surgeries with combined sciatic and adductor canal nerve block.

Timeline

Start
2020-06-15
Primary completion
2020-09
Completion
2020-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified 13.3 mg/ml Other
Comparator Bupivacaine Other / unclassified Other

Indications